Cigna launched Health Sense while Piper Sandler raised Cigna Group stock target to USD 370
Published on 10/09/2026 at 15:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Cigna launched Health Sense on October 6, 2026, targeting a 10.00 percent reduction in inefficient spending by 2030.
- Piper Sandler raised its Cigna target from USD 346.00 to USD 370.00 on October 2, 2026.
- Second-quarter 2026 revenue reached USD 71.70 billion, while adjusted earnings per share came to USD 7.78.
- The next earnings report is scheduled for October 29, 2026, according to Gekko.
Cigna Group (ISIN US1255231003) had launched Health Sense on October 6, 2026, while Piper Sandler raised its target for Cigna Group stock from USD 346.00 to USD 370.00 on October 2, 2026. Gekko reported that the initiative aims to reduce inefficient spending by 10.00 percent by 2030, while Investing.com detailed the target increase.
Three milestones shape the story
The chronology begins on July 30, 2026, when Cigna reported second-quarter revenue of USD 71.70 billion and adjusted earnings per share of USD 7.78. Fortune recorded that Specialty and Care Services delivered pre-tax adjusted earnings growth of 22.00 percent year over year.
On September 30, 2026, Cigna held its Investor Day and outlined a USD 3.00 billion modernization initiative, according to el fondo. On October 6, 2026, Health Sense became the latest milestone, with a stated 10.00 percent spending-reduction goal by 2030.
What does the growth plan mean?
The financial framework combines a near-term earnings increase with a longer-term target. Investing.com reported that Piper Sandler kept an Overweight rating and cited Cigna's 10.00 percent to 14.00 percent long-term adjusted earnings-per-share compound annual growth target, alongside a USD 45.00 adjusted earnings-per-share floor for fiscal 2030.
The second-quarter comparison was also constructive: adjusted earnings per share of USD 7.78 exceeded the USD 7.59 consensus cited by Investing.com, while revenue of USD 71.70 billion topped the USD 70.18 billion expectation. The counter-factor is execution risk around Evernorth's transition to a rebate-free pharmacy-benefit model and Cigna's January 1, 2027 exit from the ACA Marketplace.
Dates and the trading picture
The next two dated items are the October 29, 2026 earnings report and the January 1, 2027 ACA Marketplace exit. Gekko lists October 29, 2026 as the next earnings date, while Investing.com identifies the ACA transition date.
At Lang & Schwarz, Cigna Group stock was trading at EUR 250.80 on October 9, 2026 at 3:08 p.m. CEST, up 0.04 percent versus the prior close of EUR 250.70. The NYSE quote was USD 281.03 on October 8, 2026 at 4:00 p.m. ET, with a 52-week range of USD 239.51 to USD 311.34 and market capitalization of USD 74.30 billion.
The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.
Cigna Group stock facts
- Company: Cigna Corporation
- ISIN: US1255231003
- Ticker: CI
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 9, 2026, 3:08 p.m. CEST): EUR 250.80
- Change versus prior close: plus 0.04 percent
- Prior close Lang & Schwarz (October 8, 2026): EUR 250.70
- Market capitalization: USD 74.30 billion (as of October 8, 2026)
- 52-week range: USD 239.51-311.34 (as of October 8, 2026)
- Sector / Industry: Health Care / Health Care Providers & Services
- Index membership: S&P 500
- Next earnings date: October 29, 2026
Market context: Market report S&P 500.
